financetom
Business
financetom
/
Business
/
Foresight Autonomous Subsidiary Signs Collaboration Deal on Advanced Driver Assistance Systems; Shares Rise Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Foresight Autonomous Subsidiary Signs Collaboration Deal on Advanced Driver Assistance Systems; Shares Rise Pre-Bell
Dec 20, 2024 4:57 AM

07:30 AM EST, 12/20/2024 (MT Newswires) -- Foresight Autonomous Holdings ( FRSX ) said Friday its Eye-Net Mobile unit signed a multi-phase agreement with SoftBank and a Japanese vehicle manufacturer for a collaboration on advanced driver assistance systems.

The companies agreed to evaluate the use of Eye-Net's cellular vehicle-to-everything technology in advanced driver assistance systems.

Foresight said Eye-Net is conducting a paid proof-of-concept project, with support from SoftBank's cellular network infrastructure, to explore the integration of the unit's collision avoidance offering into the automaker's vehicle systems in the future.

According to the company, the first phase of the collaboration will assess the Eye-Net Sense demonstration kit. The successful evaluation will lead to the second phase of integrating Eye-Net Sense into the vehicle manufacturer's infotainment systems.

Foresight Autonomous ( FRSX ) rose more than 20% in recent premarket activity Friday.

Price: 1.11, Change: +0.19, Percent Change: +20.65

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EXPLAINER-Family feud over Korea's zinc giant threatens to affect supply chain
EXPLAINER-Family feud over Korea's zinc giant threatens to affect supply chain
Oct 4, 2024
SEOUL, Oct 4 (Reuters) - Korea Zinc, the world's biggest refined zinc producer, has been embroiled in a bitter feud among founding families over control of its $12 billion zinc empire. The winner of the battle stands to control South Korea's significant player in a U.S.-led effort to reduce heavy reliance on China for key metals and materials used in...
BRIEF-Hilton Family Sports Limited Partnership Reports 9.2% Passive Stake In UWM Holdings Corp
BRIEF-Hilton Family Sports Limited Partnership Reports 9.2% Passive Stake In UWM Holdings Corp
Oct 4, 2024
Oct 3 (Reuters) - UWM Holdings Corp ( UWMC ): * HILTON FAMILY SPORTS LIMITED PARTNERSHIP REPORTS 9.2% PASSIVE STAKE IN UWM HOLDINGS CORP AS OF OCT 3 - SEC FILING Source text for Eikon: Further company coverage: ...
EU top court sides with activist Schrems in privacy dispute with Meta
EU top court sides with activist Schrems in privacy dispute with Meta
Oct 4, 2024
BRUSSELS (Reuters) - Europe's top court on Friday sided with Austrian privacy activist Max Schrems in his privacy dispute with Meta Platforms. Schrems had taken his grievance to an Austrian court, saying he had been targeted by advertisements directed at homosexuals as a result of Meta's personalised advertising based on processing of personal data. The court subsequently sought guidance from...
Update: Summit Therapeutics Closes Phase 3 Lung Cancer Study Enrollment, Gets FDA Fast Track; Shares up Premarket
Update: Summit Therapeutics Closes Phase 3 Lung Cancer Study Enrollment, Gets FDA Fast Track; Shares up Premarket
Oct 4, 2024
05:03 AM EDT, 10/04/2024 (MT Newswires) -- (Updates with the stock move and FDA fast track in the headline and the last two paragraphs.) Summit Therapeutics ( SMMT ) said late Thursday that it completed enrollment in its late-stage HARMONi clinical trial from North America, Europe, and China, with topline data expected in mid-2025. The study is evaluating ivonescimab plus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved